Member of the European Molecular Biology Organization (EMBO)
Fellow of The Academy of Medical Sciences, United Kingdom
Kairbaan Hodivala-Dilke mainly investigates Cell biology, Integrin, Pathology, Angiogenesis and Neovascularization. His Cell biology research is multidisciplinary, incorporating perspectives in Ex vivo, Endocrinology, Internal medicine, Endothelium and Vascular endothelial growth factor A. His studies in Integrin integrate themes in fields like Fibronectin, Focal adhesion and Keratinocyte.
The study incorporates disciplines such as Integrin alphaVbeta3, Cancer and Pericyte in addition to Pathology. His biological study spans a wide range of topics, including Endothelial stem cell, Mural cell and Signal transduction. Kairbaan Hodivala-Dilke combines subjects such as Hemostasis and Cre recombinase, Genetically modified mouse with his study of Neovascularization.
His main research concerns Angiogenesis, Cancer research, Cell biology, Integrin and Neovascularization. His Angiogenesis study incorporates themes from Endothelial stem cell, Ex vivo, Immunology, Pathology and Vascular endothelial growth factor A. His research in the fields of Bone marrow and Stroma overlaps with other disciplines such as Population.
His research integrates issues of Cancer, Metastasis and Function in his study of Cancer research. He usually deals with Cell biology and limits it to topics linked to Internal medicine and Oncology. Beta is closely connected to Alpha in his research, which is encompassed under the umbrella topic of Integrin.
Kairbaan Hodivala-Dilke spends much of his time researching Cancer research, Angiogenesis, Integrin, Endothelial stem cell and Metastasis. His Cancer research study integrates concerns from other disciplines, such as Blood vessel, Tyrosine kinase and Phosphorylation, Focal adhesion. His Angiogenesis research is multidisciplinary, relying on both Heart disease, Cilengitide and Cell biology.
His work on PI3K/AKT/mTOR pathway as part of general Cell biology study is frequently linked to Dual role, therefore connecting diverse disciplines of science. His Integrin research is multidisciplinary, incorporating elements of Alpha, Antagonist, Beta, Conformational change and Peptide. His Endothelial stem cell research focuses on Cancer and how it relates to Doxorubicin, Integrin alphaVbeta3 and Chemotherapy.
Kairbaan Hodivala-Dilke mostly deals with Angiogenesis, Cancer research, Neovascularization, Stromal cell and Endothelial stem cell. His Angiogenesis study combines topics in areas such as Cell biology, Proto-oncogene tyrosine-protein kinase Src, Phosphorylation, Focal adhesion and Integrin. His Cell biology research incorporates elements of Phenotype and Pericyte.
Kairbaan Hodivala-Dilke is studying Integrin alphaVbeta3, which is a component of Integrin. His work deals with themes such as Transcriptome and Endothelium, which intersect with Cancer research. In Endothelial stem cell, Kairbaan Hodivala-Dilke works on issues like Immunology, which are connected to Blood vessel, Tyrosine kinase and Paracrine signalling.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
β3-integrin–deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
Kairbaan M. Hodivala-Dilke;Kevin P. McHugh;Dimitrios A. Tsakiris;Helen Rayburn.
Journal of Clinical Investigation (1999)
Enhanced Pathological Angiogenesis in Mice Lacking beta3 Integrin or beta3 and beta5 Integrins
Louise E. Reynolds;Lorenza Wyder;Julie C. Lively;Daniela Taverna.
Nature Medicine (2002)
Bone marrow contributes to renal parenchymal turnover and regeneration
Richard Poulsom;Stuart J. Forbes;Kairbaan Hodivala-Dilke;Eoin Ryan.
The Journal of Pathology (2001)
Mice lacking β3 integrins are osteosclerotic because of dysfunctional osteoclasts
Kevin P. McHugh;Kairbaan Hodivala-Dilke;Ming-Hao Zheng;Noriyuki Namba.
Journal of Clinical Investigation (2000)
Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts.
Natalie C. Direkze;Kairbaan Hodivala-Dilke;Rosemary Jeffery;Toby Hunt.
Cancer Research (2004)
α3β1 Integrin Is Required for Normal Development of the Epidermal Basement Membrane
C. Michael DiPersio;Kairbaan M. Hodivala-Dilke;Rudolf Jaenisch;Jordan A. Kreidberg.
Journal of Cell Biology (1997)
Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors
Andrew R Reynolds;Andrew R Reynolds;Ian R Hart;Alan R Watson;Jonathan C Welti.
Nature Medicine (2009)
Use of the mouse aortic ring assay to study angiogenesis
Marianne Baker;Stephen D Robinson;Tanguy Lechertier;Paul R Barber.
Nature Protocols (2012)
Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies
Sheila E. Francis;Keow Lin Goh;Kairbaan Hodivala-Dilke;Bernhard L. Bader.
Arteriosclerosis, Thrombosis, and Vascular Biology (2002)
Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon
M Brittan;T Hunt;R Jeffery;R Poulsom.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: